98 related articles for article (PubMed ID: 3487389)
1. In vitro activity of flurithromycin, a novel macrolide antibiotic.
Gialdroni Grassi G; Alesina R; Bersani C; Ferrara A; Fietta A; Peona V
Chemioterapia; 1986 Jun; 5(3):177-84. PubMed ID: 3487389
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System.
Periti P; Nicoletti P; Novelli A
Chemioterapia; 1985 Apr; 4(2):156-60. PubMed ID: 3924422
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
4. In vitro activity of macrolides on human phagocytic functions.
Fietta A; Bersani C; Santagada T; Bertoletti R; Gialdroni Grassi G
Chemioterapia; 1987 Feb; 6(1):52-6. PubMed ID: 3829136
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial profile of flurithromycin, a new macrolide.
Saverino D; Debbia EA; Pesce A; Lepore AM; Schito GC
J Antimicrob Chemother; 1992 Sep; 30(3):261-72. PubMed ID: 1452490
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the ketolide ABT-773.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
[TBL] [Abstract][Full Text] [Related]
7. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
9. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
Mascellino MT; Catania S; De Vito ML; De Bac C
Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of flurithromycin against some genital pathogens.
Furneri PM; Tempera G; Lepore AM; Bonfanti C; Nicoletti G
Drugs Exp Clin Res; 1991; 17(3):175-80. PubMed ID: 1914844
[TBL] [Abstract][Full Text] [Related]
13. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
Kuenzi B; Segessenmann C; Gerber AU
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
Dette GA; Knothe H; Koulen G
Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
[TBL] [Abstract][Full Text] [Related]
15. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
[TBL] [Abstract][Full Text] [Related]
17. [Bacteriostatic and bactericidal effect of cefotaxime combinations on Staphylococcus aureus assessed by FIC and FBC-index determination].
Reynaud A; Drugeon HB; Courtieu AL
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):545-9. PubMed ID: 3911153
[TBL] [Abstract][Full Text] [Related]
18. [Bacteriostatic effect of tetracyclines-macrolides associations].
de Lajudie P
Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549
[No Abstract] [Full Text] [Related]
19. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
Sultan N; Cirak MY; Erbaş D
Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
[TBL] [Abstract][Full Text] [Related]
20. [Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo].
Labro MT; Bryskier A; Babin-Chevaye C; Hakim J
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):711-4. PubMed ID: 2847106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
